space
space

Get in Touch

spacer(91)-20-49072626
Sunday
Apr 19, 2015
subscribe
You are here article details
 

Aurobindo Pharma Gets USFDA Approval For Generic Diovan HCT

By Shrikant Akolkar | 3/22/2013 3:42 PM Friday

Aurobindo Pharma has reported receiving final approval for the Valsartan and Hydrochlorothiazide tablets (brand name Diovan HCT held by Novartis). The drug is indicated in the treatment of hypertension to lower blood pressure. The market size of this drug is USD 1.7 billion (Rs 9350 crore) as per the company’s BSE filings. Aurobindo has said that the product is ready for launch and that this will happen soon.

Drug major Mylan has already launched an authorised generic version of this drug in USA. We believe that Aurobindo is the first to launch the generic of this drug considering that Mylan’s was an authorised generic.

We spoke to the company spokesperson, who declined to comment on the pricing and market share of the drug. However, he did say that the company expects to see about 3-4 generic players in the market. Considering this, about 20% market share looks achievable for Aurobindo. Since it is the first to launch, there would not be a massive erosion of price initially. However, as the drug has already fallen out of patent cover, new players would try to enter the market as faster as possible. Once other companies start launching their versions of the drug, the price will go down.

Considering 80% price erosion and 10% market share for Aurobindo, it can be estimated that the company may achieve revenues of about Rs 700 crore from the drug. Of course, these numbers are based on the assumption that the company makes the best of this opportunity.

With this approval, Aurobindo Pharma has a total of 181 ANDA approvals from USFDA, of which 156 are final and 25 are tentative approvals.

Find More Articles on: Markets, DSIJ Mindshare, Product, Large Cap

Related Readings

Top 10 companies with Lowest Foreign Institutional Investors (FIIs) Holding in BSE 100 Companies

DSIJ.in Exclusive

LatestMost PopularMarket Action

Market In Bears Grip, Nifty Touches 8600 Mark

This was the third consecutive session that the Indian markets closed below its previous close. The sectoral indices like Healthcare, Bankex and Auto were hammered badly and broke all the vital supports.   Mid-Caps and Small-Caps also tanked and fell by more than 150 points each. The Nifty continued with the negative momentum and was down by 100 points and closed at 8606 while Sensex was down by 223 points and closed at 28442 in today’s trade.

Index Trends And Stocks In Action April 17, 2015

Indian equity market extended its fall for second consecutive session led by constant selling pressure in the Pharma, Banking and Capital goods stock. Nifty after forming Bearish Engulfing candlestick on Wednesday followed it will a bearish candlestick.

Market Is Likely To Open Weak

Asian shares edged up in early trade on Friday, on track to score weekly gains and shrugging off a languid performance on Wall Street after another set of lackluster U.S. economic data. SGX Nifty is trading at flat. Indian market is likely to open weak. Crisil, Delta Corp, RS Software and Reliance Ind would be reporting fourth quarter earnings today.

Taxation On Redemption Of Gold Bond

Jayesh Dadia, Chartered Accountant

Breaking News

Muthoot Group Steps Into Home Loan Sector

The Muthoot Group that was majorly into gold loan portfolio has entered into the home loan segment with the launch of ‘Muthoot Homefin’ in Kochi. The housing loan vertical forms Muthoot’s 17th division. Muthoot Homefin will extend housing fi nance to enable customers to fulfill their dream to build/acquire a residential space of their own. Muthoot Homefin services for the customers were launched from April 15 onwards. Muthoot Homefin will offer housing loans from Rs 1 lakh to Rs 500 lakh at interest rates from 10.20 per cent p.a onwards for periods up to 30 years. Repayment of the amount shall be through equated monthly installments and on diminishing balance basis. Loan Against Property (LAP) will be offered in the range of  Rs 10 lakh to Rs 5 crore for a period up to 15 years with interest rate of 13 per cent onwards.

Dollar Index: GOING BACK AND FORTH

The uncertainty over the US’ economy and other global concerns has put the Dollar Index under pressure but it is likely to remain supported for the coming months

Naveen Mathur, Associate Director - Commodities & Currencies, Angel Commodities Broking (P) Ltd.

Kerbside

The recommendations provided in this column are taken from different market sources such as brokers, analysts, dealers and investment strategists, etc. These recommendations may not be backed by strong fundamentals. Dalal Street Investment Journal may or may not subscribe to these recommendations.

MULTI-ASSET CLASS FUNDS: A CLOSER LOOK

Should multi-asset class funds be a part of your portfolio considering it has both pros and cons?

Hemant Rustagi, CEO, Wiseinvest Advisors

FTP 2015-20: QUEST TO PUT INDIA ON GLOBAL TRADING MAP

The new FTP, according to the government, will help synchronize Indian trade with the new global scenario. Amit Bhanot takes a closer look at how these transformations will create a more positive scenario

An objective to touch export target of USD 900 billion by 2020.

Scrips that are being issued for basic custom duty under this would be freely transferrable for any kind of use.

Subsidies are now passé and the whole global trading space will change with competition being the key factor

Stock Recommendations For Your Portfolio

The scrips in this column have been recommended with a short-term investment horizon in mind and carry high risk. Therefore, investors are advised to take into account their risk appetite before investing, as fundamentals may or may not back the recommendations.

DSIJ Breakfast News

Start your day with DSIJ Breakfast Roundup, wind up with DSIJ Market Roundup. Register now to get the day’s market outlook, global cues, economic trends, top corporate news delivered straight to your inbox.

mail to

Start your day with DSIJ Breakfast Roundup, wind up with DSIJ Market Roundup. Register now to get the day’s market outlook, global cues, economic trends, top corporate news delivered straight to your inbox.

mail to  *
 *
 *
 *
 *
 *
Content

WE VALUE YOUR FEEDBACK

(* No Research/Stock Queries)
Name :
Email ID :
Cell Number :
Message :
Content